Clinical Trial Detail

NCT ID NCT03665285
Title A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NextCure, Inc.
Indications

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

Advanced Solid Tumor

ovarian cancer

lung non-small cell carcinoma

Therapies

NC318

Age Groups: senior adult

No variant requirements are available.